<SEC-DOCUMENT>0001641172-25-004585-index.html : 20250414 <SEC-HEADER>0001641172-25-004585.hdr.sgml : 20250414 <ACCEPTANCE-DATETIME>20250414164518 ACCESSION NUMBER: 0001641172-25-004585 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ernexa Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 25836505 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 18A CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 798-6700 MAIL ADDRESS: STREET 1: 10531 4S COMMONS DRIVE STREET 2: SUITE 166-550 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Eterna Therapeutics Inc. DATE OF NAME CHANGE: 20221017 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>formdef14a.htm <TEXT> Document 1 - file: formdef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>def14a_001.jpg <TEXT> Document 2 - file: def14a_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>def14a_002.jpg <TEXT> Document 3 - file: def14a_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>def14a_004.jpg <TEXT> Document 4 - file: def14a_004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>proxy_001.jpg <TEXT> Document 5 - file: proxy_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>proxy_002.jpg <TEXT> Document 6 - file: proxy_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>7 <FILENAME>erna-20241231.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 7 - file: erna-20241231.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>8 <FILENAME>erna-20241231_def.xml <DESCRIPTION>XBRL DEFINITION FILE <TEXT> Document 8 - file: erna-20241231_def.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>9 <FILENAME>erna-20241231_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 9 - file: erna-20241231_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>10 <FILENAME>erna-20241231_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 10 - file: erna-20241231_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: R2.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>R3.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: R3.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>R4.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 15 - file: R4.htm
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>17 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>19 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: FilingSummary.html
Document 19 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>21 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 21 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>22 <FILENAME>0001641172-25-004585-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 22 - file: 0001641172-25-004585-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>23 <FILENAME>formdef14a_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 23 - file: formdef14a_htm.html
Document 23 - RAW XML: formdef14a_htm.xml
</DOCUMENT> </SEC-DOCUMENT>